![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » LAM IPM WOUND GEL(TM) RECEIVES COSTA RICAN GOVERNMENT SALES AND MARKETING CLEARANCE
LAM IPM WOUND GEL(TM) RECEIVES COSTA RICAN GOVERNMENT SALES AND MARKETING CLEARANCE
LAM Pharmaceutical, Corp. (OTC BB: LAMP -- News; Frankfurt: LAM -- News; Berlin: LAM -- News), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that Ministerio de Salud Republica Costa Rica, Direccion de Registros y Controles (Ministry of Health, Republic of Costa Rica, Directorate of Registrations and Controls) granted LAM Pharmaceutical a clearance to market and sell its patented and proprietary LAM IPM Wound Gel(TM) in Costa Rica, under the registration code DRC-19902.
Yahoo News (http://biz.yahoo.com/prnews/050921/ukw006.html?.v=28)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct